Please check your internet connection and try again.
# Miconazole vaginal pessary
## Overview
- **Classification**: Azole Antifungal
- **Mechanism**: Inhibits ergosterol synthesis by interfering with fungal cytochrome P450 activity, disrupting the fungal cell membrane.
## Primary Indications
1. **Vulvovaginal Candidiasis** - Treatment of yeast infections caused by *Candida* species.
## Adult Dosing
### Standard Dosing
**Vulvovaginal Candidiasis**
- **Option 1 (3-day)**
- **Dose**: **200 mg**
- **Frequency**: Once daily, at bedtime
- **Route**: Vaginal
- **Duration**: **3 days**
- **Option 2 (7-day)**
- **Dose**: **100 mg**
- **Frequency**: Once daily, at bedtime
- **Route**: Vaginal
- **Duration**: **7 days**
- **Option 3 (Single-dose)**
- **Dose**: **1200 mg**
- **Frequency**: Single dose
- **Route**: Vaginal
- **Duration**: **1 day**
### Dose Adjustments
- **Renal Impairment**: No specific adjustment needed; minimal systemic absorption.
- **Hepatic Impairment**: No specific adjustment needed; minimal systemic absorption.
- **Elderly Patients**: No specific adjustments beyond standard adult dosing.
## Pediatric Dosing
### Neonates (0-28 days)
- **Not Recommended**: Miconazole vaginal pessaries are not indicated for neonates.
### Infants (1-12 months)
- **Not Recommended**: Miconazole vaginal pessaries are not indicated for infants.
### Children (1-12 years)
- **Not Recommended**: Miconazole vaginal pessaries are not indicated for pre-pubertal children due to lack of studies and anatomical considerations.
### Adolescents (13-18 years)
- **Indication**: Vulvovaginal Candidiasis
- **Dose**: Follow adult dosing regimens (e.g., **200 mg** once daily for **3 days**; or **1200 mg** single dose).
- **Maximum**: Adult maximum dose for chosen regimen.
- **Special Notes**: Ensure appropriate diagnosis of vaginal candidiasis.
## Safety Information
### Contraindications
- **Absolute**: Hypersensitivity to miconazole or any component of the formulation.
- **Absolute**: Known hypersensitivity to other azole antifungals.
### Common Adverse Effects
- **Very Common (>10%)**: Vaginal burning, itching, irritation.
- **Common (1-10%)**: Headache, abdominal cramps, pelvic pain.
- **Serious but Rare**: Severe allergic reactions (rash, hives, swelling, difficulty breathing).
### Key Drug Interactions
- **Warfarin**: Vaginal miconazole can inhibit warfarin metabolism, increasing INR and bleeding risk. Monitor INR closely, adjust warfarin dose as needed.
- **Latex Products (condoms/diaphragms)**: Components in the pessary may damage latex, reducing contraceptive efficacy. Advise alternative birth control during treatment.
## Monitoring & Follow-up
- **Before Treatment**: Confirm diagnosis of vulvovaginal candidiasis; rule out other infections.
- **During Treatment**: Monitor for symptom improvement; watch for signs of worsening irritation or allergic reaction.
- **Clinical Signs**: Persistent or worsening symptoms may indicate resistant infection or misdiagnosis.
## Clinical Pearls
- 💡 **Complete Course**: Counsel patients to complete the entire course of treatment, even if symptoms improve early.
- 💡 **Bedtime Administration**: Recommend administration at bedtime for better drug retention and reduced leakage.
- 💡 **Sexual Activity**: Advise patients to avoid sexual intercourse during treatment to prevent irritation and re-infection.
- 💡 **Hygiene**: Avoid douching or using tampons during treatment.
> **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.
